Sales Contact

T: +33 1 8362 9036

Industry Publications

"Long Term Care for the Elderly in France, European Comparison", 2011

Industry Report published by Candesic, Deomenos and Epsilon Research

Click here for preview


> Order an Epsilon Market Report (starting at €950) > mail

NB: includes access to the underlying EMAT reports

Alert on Reports Published
Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.


Follow the sector on Twitter

Epsilon Research covers the M&A transactions for the "Health, Pharmaceuticals & Biotechnology" industry [1114 EMAT Reports], which includes:


Our analysts publish transaction multiples reports for private company M&A deals (announced 2004 onwards).

Each report presents detailed information on the deal value, structure and rationale, the target's activity, history and financial information; it includes the calculation of the key historic and current multiples: enterprise value over sales (EV/S), EBITDA (EV/EBITDA), or EBIT (EV/EBIT), P/E and Price to Book. All information sources are systematically given and company financials are carefully verified and restated if needed.


The reports are a unique source of information to have a comparable metric for the valuation of a private company, establish the "market value" of an investment or private equity investment portfolios.


The deal reports are published in Epsilon's EMAT database.
For an example of EMAT report, please click on this link.
If you wish to buy an EMAT Report, and you are not a customer, please contact us.


Recent M&A Deal Reports Published on EMAT

Date Acquirer Target Country Industries Valuation multiples See details
31/07/2023 Mindray Medical Netherlands DiaSys Diagnostic Systems Germany Diagnostic Medical Equipment * 113498
18/07/2023 Groupe Vabel Laboratoires Sarbec Nord Personal Products * 113988
29/06/2023 Donaldson Univercells Technologies Belgium Industrial Machinery, Medical Equipment *** 113582
16/05/2023 Shandong Sinocera Functional Material Co DEKEMA Dental-Keramikoefen Germany Medical Equipment *** 112784
28/04/2023 PI Industries Archimica Italy Specialty Chemicals, Laboratory Testing Services ** 112912
24/04/2023 Private Group backed by Vivalto Partners Laboratoires Delbert France Pharmaceuticals, Biomedical Research Laboratory * 112600
19/04/2023 Koninklijke DSM Adare Pharmaceuticals (Adare Biome) Yvelines Pharmaceuticals *** 112493
14/03/2023 Private Group backed by Bpifrance, NewAlpha Verto Capital and BNP Paribas Development Lessonia Finistère Personal Products ** 112641
07/02/2023 Richter Gedeon Vegyeszeti Gyar Nyrt OC Distributors Ireland Pharmaceuticals * 112238
03/02/2023 Crown Energy SmarTee (Accyourate Group) Italy Medical Supplies, e-services (B2C) ** 112231
01/02/2023 Advanced Medical Solutions Group Connexicon Medical Ireland Medical Supplies ** 112196
24/01/2023 Private Group led by Apax Partners Porsolt Mayenne Biomedical Research Laboratory ** 111888
23/12/2022 TFS International Appletree CI Group Switzerland Biomedical Research Laboratory * 111944
20/12/2022 Fielmann Medop | Ibervision Servicios Opticos | Elaboria Spain Specialised R&W, Medical Supplies, Eyewear (retail) * 111182
07/10/2022 Evergreen Healthcare Castlebridge Manor Nursing Home Ireland Care Home * 111002
08/09/2022 DCC Medi-Globe Technologies Germany Medical Supplies ** 109928
06/09/2022 ADDvise Group CliniChain Netherlands Medical Equipment ** 109947
30/08/2022 Neurocrine Biosciences Diurnal Group Wales Biotechnology, Biomedical Research Laboratory *** 109861
08/08/2022 Azenta B Medical Systems Luxembourg Medical Equipment *** 109985
03/07/2022 Private Group led by Adagia Minlay Paris Medical Implants or Prostheses Manufacturers * 109372
About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Database
Epsilon Multiple Analysis Tool
The Reference Source for Private Company Acquisition Multiples

Test & Subscribe
EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).


► Example of EMAT Report